3D Array Technology LLC (3DAT) is a leader on the functional materials innovation, development and supply. As a high performance materials supplier and cutting-edge contract research service company, 3DAT always dedicated on finding the best solutions for our customers.
Allyx Therapeutics is a clinical stage biotechnology company based in CT. We are targeting synapse preservation as a disease-modifying approach for treating Alzheimer’s disease. Our lead candidate ALX-001 is an orally bioavailable small molecule drug which acts as a silent allosteric modulator of mGluR5 to selectively block Prion Protein initiated synaptic dysfunction. ALX-001 reversed cognitive impairment and rescued synapse loss in multiple aged transgenic mouse models of AD. The FDA has approved the IND-application for this program with first in human administration of ALX-001 in healthy volunteers currently underway.
Aqualumos develops technology to eliminate toxic “Forever Chemicals” (PFAS) in water.
Arome is bringing new approaches in analytical and computational mass spectrometry to the commercial space. We are a team of dedicated chemists, data analyst and software engineers working to gain new knowledge using our mass spectrometry platform. Our goal is to enable our clients to leverage the tools and approaches developed over many decades of innovation in drug and natural product development.
Azitra is a clinical stage medical dermatology company that leverages its extensive knowledge of proteomics, genetic engineering and the skin microbiome to create and develop novel products for the treatment of skin conditions and diseases.
Bactana isolates molecules expressed from commensal anaerobic bacteria to create therapies for pets that treat metabolic conditions and digestive disorders, while also developing sustainable products to reduce antibiotics and natural resource requirements during livestock production.
Bastion is developing an in-home device with a smartphone-based automated analyzer to measure semen quality.
Biorasis was formed to commercialize a minimally- invasive glucose and bio-analyte biosensor for use in drug development and eventually in human on-demand metabolic disease management
CaroGen Corporation has developed transformative virus-like vesicles (VLVs) technology that can be exploited to generate safe but potent vaccines to treat various diseases.
CytoVeris has been founded with the vision to fill an unmet need for innovative new tools that enable surgical oncologists to ‘ID’ and remove all tumor tissue in real-time during cancer resection surgical procedures.
Debogy is a stealth start-up with proprietary technology that can modify molecular surface structures to electrostatically destroy viral, bacterial, and fungal cells on contact
Enable Life Sciences facilitates Innovation in the life sciences. We bring the innovative plans and aspirations of our clients to reality through Planning, Creation and Execution. We enable success through customized Innovation Management and R&D Project Management services, including collaborations at a global scale.
Encapsulate is developing an automated tumor-on-a-chip system that can grow patients cancer cells outside the body, and test the efficacy of chemotherapeutic drugs against them to advocate for the best course of treatment.
EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets which are expressed on multiple immune cell types. The company's platform will generate first-in-class treatments for unmet needs in oncology and autoimmune diseases.
ImStem Biotechnology, Inc.,is focusing on developing off-the-shelf cell-therapy product derived from human pluripotent stem cells(hPSC) for regeneration and autoimmune diseases treatment.
LambdaVision, Inc. (LVI) is developing a high-resolution, protein-based retinal implant to restore vision to the millions of patients blinded by retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD)
TIP Success Story
Bactana Signs Agreement with ArcaNatura
Bactana Signs Agreement with ArcaNatura to launch Bactana’s first commercial product, Pawsni™ Glucose Control.
Mitotherapeutix aims to develop novel therapeutics based on new discoveries in the control of cellular metabolism particularly in key mitochondria regulators.
NANOIONIX, LLC is developing advanced ceramic materials with breakthrough performance, solving some of the world’s most challenging problems in healthcare and energy technology.
Oscillo Biosciences is developing technologies and software for analyzing audio and other time-based signals, including music and speech.
Potentiometric Probes develops and supplies voltage-sensitive dyes for academic and pharmaceutical industry researchers.
QCDx is creating novel diagnostics for personalized and early cancer detection based on a standard blood sample.
Quercus Molecular Design (QMD) is a UConn-based startup specializing in the rational design of small molecules that simultaneously inhibit multiple essential protein targets to enhance potency and slow the onset of drug resistance.
Rallybio’s ambition is to identify and accelerate the development of transformative therapies for patients with severe and rare disorders.
Intus Bio is using its proprietary high-resolution, high-throughput assay and analysis technology to identify bacteria and deliver answers about the microbiome, with unprecedented detail, accuracy and scale.
Solution Spray Technologies has an exclusive license to innovative UConn solution precursor plasma spray technology (SPPS) that leverages two decades of R&D at UConn. SPPS technology provides high-value coatings solutions to address several major industrial problems and challenges.
The Feel Good Lab has developed over-the-counter pain creams for arthritis sufferers, athletes, and everyone inbetween. Getting extra relief used to require compromising your overall health with pills like ibuprofen or smelly pain creams that contain toxic fillers and preservatives.
Torigen Pharmaceuticals, Inc. is focused on providing veterinary cancer solutions for companion animals. Their product, VetiVax(TM) is a novel, personalized immunotherapy that uses the animals’ own tumor cells to fight cancer.
Vanessa Biotech is a biomedical company committed to making an impact on healthcare markets that are often overlooked.
